A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
NCT04978506 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 83
Last updated 2025-01-13
Summary
The main objectives of this trial are to investigate (1) safety, tolerability, pharmacokinetics and pharmacodynamics following multiple rising doses of BI 1569912; (2) tolerability of BI 1569912 in an up-titrating dosing scheme.
Conditions
- Healthy
Interventions
- DRUG
-
BI 1569912
BI 1569912
- DRUG
-
Placebo
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-03
- Primary Completion
- 2024-07-04
- Completion
- 2024-07-04
Countries
- Germany
Study Locations
More Related Trials
-
A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated
NCT04439838 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043
NCT04789304 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Men Tolerate Different Doses of BI 3006337
NCT05076422 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
NCT04666922 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
NCT06081530 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
NCT01611311 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses
NCT01505894 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
NCT03608072 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
NCT06148948 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
NCT06494774 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
NCT05469646 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
NCT03195088 ·Status: TERMINATED ·Phase: PHASE1
-
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
NCT03349723 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
NCT01958060 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers
NCT02244203 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
NCT03747926 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT03868540 ·Status: TERMINATED ·Phase: PHASE1
-
A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men
NCT03875001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated
NCT06310005 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
NCT01650155 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
First in Man Trial of BI 113608
NCT01540825 ·Status: COMPLETED ·Phase: PHASE1